West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook

Dow Jones

Oct 24, 2024

By Denny Jacob

West Pharmaceutical Services shares rose 19% after raising its outlook for the year.

Shares were trading around $341.77. The stock is on pace for its largest percentage increase on record and is currently the best performer in the S&P 500.

The pharmaceuticals, biologics, vaccines and consumer healthcare products manufacturer forecast sales between $2.88 billion and $2.91 billion as well adjusted earnings per-share in the range of $6.55 and $6.75. It previously guided for sales between $2.87 billion and $2.9 billion and adjusted earnings per-share in the range of $6.35 and $6.65.

West Pharmaceutical attributed the higher outlook in part due to favorable currency movements.

The company also reported better-than-expected sales in its third quarter. Sales edged down to $746.9 million, topping estimates of $709.6 million from analysts polled by FactSet.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

October 24, 2024 11:07 ET (15:07 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2477532036"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2477532036\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2477532036?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-24 23:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477532036","market":"sg","top_or_hot":-1,"title":"West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  West Pharmaceutical Services shares rose 19% after raising its outlook for the year. \n</p>\n<p>\n  Shares were trading around $341.77. The stock is on pace for its largest percentage increase on record and is currently the best performer in the S&amp;P 500. \n</p>\n<p>\n  The pharmaceuticals, biologics, vaccines and consumer healthcare products manufacturer forecast sales between $2.88 billion and $2.91 billion as well adjusted earnings per-share in the range of $6.55 and $6.75. It previously guided for sales between $2.87 billion and $2.9 billion and adjusted earnings per-share in the range of $6.35 and $6.65. \n</p>\n<p>\n  West Pharmaceutical attributed the higher outlook in part due to favorable currency movements. \n</p>\n<p>\n  The company also reported better-than-expected sales in its third quarter. Sales edged down to $746.9 million, topping estimates of $709.6 million from analysts polled by FactSet. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 24, 2024 11:07 ET (15:07 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWest Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-10-24 23:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  West Pharmaceutical Services shares rose 19% after raising its outlook for the year. \n</p>\n<p>\n  Shares were trading around $341.77. The stock is on pace for its largest percentage increase on record and is currently the best performer in the S&amp;P 500. \n</p>\n<p>\n  The pharmaceuticals, biologics, vaccines and consumer healthcare products manufacturer forecast sales between $2.88 billion and $2.91 billion as well adjusted earnings per-share in the range of $6.55 and $6.75. It previously guided for sales between $2.87 billion and $2.9 billion and adjusted earnings per-share in the range of $6.35 and $6.65. \n</p>\n<p>\n  West Pharmaceutical attributed the higher outlook in part due to favorable currency movements. \n</p>\n<p>\n  The company also reported better-than-expected sales in its third quarter. Sales edged down to $746.9 million, topping estimates of $709.6 million from analysts polled by FactSet. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 24, 2024 11:07 ET (15:07 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WST","symbol_name":"West Pharmaceutical Services Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2477532036","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477532036","pubTimestamp":1729782420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"West Pharmaceutical Services shares rose 19% after raising its outlook for the year.Shares were trading around $341.77. The stock is on pace for its largest percentage increase on record and is currently the best performer in the S&P 500.The pharmaceuticals, biologics, vaccines and consumer healthcare products manufacturer forecast sales between $2.88 billion and $2.91 billion as well adjusted earnings per-share in the range of $6.55 and $6.75. It previously guided for sales between $2.87 billion and $2.9 billion and adjusted earnings per-share in the range of $6.35 and $6.65.West Pharmaceutical attributed the higher outlook in part due to favorable currency movements.The company also reported better-than-expected sales in its third quarter. Sales edged down to $746.9 million, topping estimates of $709.6 million from analysts polled by FactSet.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WST":"West Pharmaceutical Services Inc","BK4567":"ESG概念","BK4588":"碎股","BK4585":"ETF&股票定投概念","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4121":"生命科学工具和服务","BK4504":"桥水持仓"},"translate_title":"West Pharmaceutical Services上调2024年展望后股价上涨19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WST":1},"content_text":"By Denny Jacob \n\n\n \n\n\n  West Pharmaceutical Services shares rose 19% after raising its outlook for the year. \n\n\n  Shares were trading around $341.77. The stock is on pace for its largest percentage increase on record and is currently the best performer in the S&P 500. \n\n\n  The pharmaceuticals, biologics, vaccines and consumer healthcare products manufacturer forecast sales between $2.88 billion and $2.91 billion as well adjusted earnings per-share in the range of $6.55 and $6.75. It previously guided for sales between $2.87 billion and $2.9 billion and adjusted earnings per-share in the range of $6.35 and $6.65. \n\n\n  West Pharmaceutical attributed the higher outlook in part due to favorable currency movements. \n\n\n  The company also reported better-than-expected sales in its third quarter. Sales edged down to $746.9 million, topping estimates of $709.6 million from analysts polled by FactSet. \n\n\n \n\n\n  Write to Denny Jacob at denny.jacob@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 24, 2024 11:07 ET (15:07 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}